title: From MDS/AML to iPSC and back again.
abstract: iPSC lines derived from MDS and AML patient samples can map clonal evolution, disease progression and regression, and identify disease stage-specific medication effects.
authors.affiliation: Department of Internal Medicine, University of California Davis, Sacramento, CA 95817, USA. Email: bajonas@ucdavis.edu.
authors.forename: Brian A
authors.initials: BA
authors.lastname: Jonas
mesh_terms: D060965:Clonal Evolution; D018450:Disease Progression; D006801:Humans; D057026:Induced Pluripotent Stem Cells; D015470:Leukemia, Myeloid, Acute; D009190:Myelodysplastic Syndromes